Jamie Webb
Jamie has been a full-time staff member at Peggy Lillis Foundation since graduating from the University of Florida with a bachelor’s of science in Health Education in 2022. At PLF, Jamie works alongside Advocates and stakeholders to help manage day-to-day operations as well as several of the organization’s Peer Support Network, National C. diff Summit and Lobby Day, Scientific Symposium, and other various educational programs.
Let’s Connect
More by this Author
American Dental Association and CDC Add Useful New Antimicrobial Stewardship Resources in 2026
Earlier this year, Centers for Disease Control and Prevention (CDC) released a new Antimicrobial Resistance (AMR or AR) communications toolkit as a part of its efforts to combat antimicrobial resistance in 2026. The toolkit is intended to help CDC’s partners communicate key talking points about AMR to the general public–and to healthcare professionals. A decade […]
Pediatric C. diff
Children & C. diff C. diff is more common and more serious in older adults, but children can get it too. About 20,000 children in the U.S. get C. diff infections every year. Children are more likely to pick up C. diff outside of the hospital, in the community, even if they haven’t taken antibiotics […]
How to Talk to Your Doctor about Antibiotics
For C. diff survivors, it can be scary to visit a healthcare setting–especially if you’re worried about taking antibiotics. If you’ve struggled to talk about antibiotics with your doctor after C. diff, read below for some things to keep in mind before your next appointment. How do I talk to my doctor about my history […]
Post-Infectious IBS: What C. diff Survivors Need to Know
After a C. diff infection is resolved, some people still experience symptoms in their gut. C. diff infections, and the treatments you take to resolve them, can do enough damage to the gut to result in a new condition called post-infectious irritable bowel syndrome (IBS). However, post-infectious IBS isn’t caused by an active C. diff […]
Fresh Faces on the Scientific Side: New Advisors at PLF
PLF’s Scientific Advisory Council recently welcomed seven experts to its ranks. From across a variety of specialties and research interests, these new SAC members are injecting fresh energy into our fight against C. diff infections. “I have been following PLF’s symposiums since my GI fellowship, and they have shaped how I think about what matters […]
2026 Summit and Lobby Day Bring New Volunteers and New Energy to D.C.
Day 1: The Summit On Monday, April 13, Peggy Lillis Foundation hosted its annual National C. diff Summit. We hosted 15 speakers who shared a range of exciting presentations on topics ranging from diagnosis and prevention to advocacy at the Food and Drug Administration. “Providing dedicated space for medical professionals, regulators, and patients in a […]
New Additions to PLF’s Scientific Advisory Council
In August, Peggy Lillis Foundation added three new experts to its Scientific Advisory Council (SAC). The SAC is an esteemed body of doctors, researchers, and other health professionals and C. diff experts. These experts provide insight into the current field of C. diff research and innovation and review PLF’s educational materials and the informational content […]
Our Year in Review
It’s been a great year for PLF and the fight against C. diff. Take a look through our highlights from the past 12 months below.
The State of Fecal Transplants
UPDATE: OpenBiome has been permitted to continue distributing FMT to patients with severe, fulminant C. diff until December 31, at which time a new judgment will be made regarding the treatment’s availability. You may have heard in recent weeks that OpenBiome, the largest distributor of fecal microbiota transplant (FMT) products in the United States, announced […]
New Clinical Research Option for Recurrent C. diff Patients
Due to the nature of C. diff infections, particularly the high recurrence rate following standard treatments, participating in a clinical trial may be an option for sufferers who don’t respond to antibiotics. Some clinical trials focus on developing vaccines and other preventatives. While Peggy Lillis Foundation does not endorse specific treatments, we make C. diff […]
Empowering Change: Highlights from the 9th Annual C. diff Advocacy Summit & Lobby Day
On April 15th, Peggy Lillis Foundation convened its ninth annual National C. diff Advocacy Summit in Washington, D.C. This year, we welcomed fresh perspectives and insights into the difficulties patients and healthcare professionals are facing in the battle against C. diff, as well as some new strategies to prevent and treat the deadly infection. What’s […]
Welcoming Paul Feuerstadt, Debbie Trinker, and David Shlaes to Our Board of Directors
On February 5, we announced the appointment of Paul Feuerstadt, MD; Debbie Trinker, BA, JD; and David Shlaes, PhD, MD to the Peggy Lillis Foundation board of directors. Read on for more about our new members. Paul Feuerstadt, MD, brings with him a deep medical knowledge of C. difficile infection and other infections of the […]
The surprising origin of a deadly hospital infection
PLF Scientific Advisor Vince Young, MD, PhD, was featured in a University of Michigan Medicine article on a recent study undergone by Dr. Young and fellow researcher Evan Snitkin, PhD, suggesting that risk for getting sick with C. diff may be more strongly associated with patients who are already colonized with the bacteria, rather than […]
Maintaining Gut Health in Senior Citizens to Prevent Clostridioides difficile Infections
Guest blog by Aging.com editor Kelly Koeppel
We did it! We reached millions of people during C. diff Awareness Month!
Results from our record-breaking fourth annual See C. diff campaign
Peggy Lillis Foundation Featured on Empowered Patient Podcast
An interview with our Executive Director
Peggy Lillis Foundation Leads Coalition to Urge FDA to Prioritize C. diff Treatments and Antibiotic Stewardship
On April 28, 2022, the Peggy Lillis Foundation for C. diff Education and Advocacy sent an open letter, cosigned by Alliance for Aging Research, the Amputee Coalition, the Antibiotic Resistance Action Center, the Infectious Disease Society of America, NTM Info & Research, OpenBiome, the Partnership to Fight Infectious Disease, and the Sepsis Alliance to the […]